Loss-of-function variants in TREX1, as identified in patients with AGS and FCL, impair DNA clearance and result in chronic activation of type I interferons (IFN) via the DNA sensing cGAS-STING pathway [8]. This evidence concerns the gene TREX1 and Aicardi-Goutieres syndrome.